Membrane Fatty Acid Composition and Cell Surface Hydrophobicity of Marine Hydrocarbonoclastic SK2 Grown on Diesel, Biodiesel and Rapeseed Oil as Carbon Sources.

The marine hydrocarbonoclastic bacterium is well known for its ability to successfully degrade various mixtures of -alkanes occurring in marine oil spills. For effective growth on these compounds, the bacteria possess the unique capability not only to incorporate but also to modify fatty intermediates derived from the alkane degradation pathway. High efficiency of both these processes provides better competitiveness for a single bacteria species among hydrocarbon degraders.

[Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].

The evaluation of bone metabolism in everyday practise is based on measurements of non-invasive bone markers. TRACP-5b has been considered as a potentially useful marker of bone resorption rate. It is an enzyme that is secreted by osteoclasts in the course of bone resorption.

[Cinacalcet in the therapy of secondary hyperparathyroidism--own experiences].

Unlabelled: Secondary hyperparathyroidism (sHPT) affects 20-25% dialysed patients and is related to the bone, mineral and cardiovascular complications. Cinacalcet, acts on the calcium-sensing receptor increasing its sensitivity to calcium, thereby reducing parathyroid hormone (PTH) secretion. The aim of this study was to evaluate the effect of cinacalcet in dialysed patients with sHPT Material and methods.

[Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].

Unlabelled: The evaluation of renal osteodystrophy in everyday practise is based on measurements of non-invasive bone markers. TRAP 5b has been considered as a potentially useful marker of bone resorption rate. We assessed the clinical usefulness of TRAP 5b as a marker of bone resorption in renal osteodystrophy in comparison with standard marker which is intact parathormone (iPTH) level.

[Usefulness of neuron specific enolase in patients with head and neck malignant tumors].

The authors present results of evaluation of neuron specific enolase (NSE) in 146 persons. We analyzed a concentration of NSE in preliminary study and in monitoring depending on clinical advances of tumour, mass of primary tumour and metastases to lymph nodes. Neuron specific enolase was excluded because the number of positive results was the same both in the main and control group.